| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.8 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |